flavanone has been researched along with Bone Loss, Osteoclastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, D; He, B; He, Y; Lei, J; Wang, B; Yang, X; Zhang, K; Zhang, Z | 1 |
| Huang, Y; Liu, Q; Quinn, JM; Song, F; Tan, R; Tickner, J; Xu, J; Yang, M; Zhang, G; Zhao, J; Zhou, L | 1 |
2 other study(ies) available for flavanone and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
A flavonoids compound inhibits osteoclast differentiation by attenuating RANKL induced NFATc-1/c-Fos induction.
Topics: Animals; Anti-Inflammatory Agents; Bone Marrow Cells; Bone Resorption; Cells, Cultured; Chromones; Flavanones; Humans; Macrophages; Mice; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Proto-Oncogene Proteins c-fos; RANK Ligand; Signal Transduction; STAT3 Transcription Factor | 2018 |
Eriodictyol Inhibits RANKL-Induced Osteoclast Formation and Function Via Inhibition of NFATc1 Activity.
Topics: Animals; Bone Marrow Cells; Bone Resorption; Cell Differentiation; Flavanones; Mice; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Proto-Oncogene Proteins c-fos; RANK Ligand; Signal Transduction | 2016 |